Citation Formats
Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. C. Guler Et Al. , "Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma," Urologia Internationalis , vol.107, no.2, pp.171-178, 2023

Guler, O. C. Et Al. 2023. Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma. Urologia Internationalis , vol.107, no.2 , 171-178.

Guler, O. C., Oymak, E., HÜRMÜZ, P., Yavas, G., TİLKİ, B., Yavas, C., ... ÖZYİĞİT, G.(2023). Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma. Urologia Internationalis , vol.107, no.2, 171-178.

Guler, Ozan Et Al. "Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma," Urologia Internationalis , vol.107, no.2, 171-178, 2023

Guler, Ozan C. Et Al. "Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma." Urologia Internationalis , vol.107, no.2, pp.171-178, 2023

Guler, O. C. Et Al. (2023) . "Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma." Urologia Internationalis , vol.107, no.2, pp.171-178.

@article{article, author={Ozan Cem Guler Et Al. }, title={Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma}, journal={Urologia Internationalis}, year=2023, pages={171-178} }